These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31722837)

  • 41. Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
    Kennard A; Hawley C; Tate J; Klingberg S; Pretorius C; Hutchison C; Mollee P
    Clin Chem Lab Med; 2016 Jun; 54(6):1045-52. PubMed ID: 26684350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of antithyroid autoimmunity as a predictive biomarker of chronic immune thrombocytopenia.
    Giordano P; Urbano F; Lassandro G; Bianchi FP; Tolva A; Saracco P; Russo G; Notarangelo LD; Gabelli M; Cesaro S; Wasniewska M; Faienza MF
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27452. PubMed ID: 30270575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
    Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
    Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiplatelet antibodies and their correlation with clinical findings in childhood immune thrombocytopenic purpura.
    Yildirmak Y; Yanikkaya-Demirel G; Palanduz A; Kayaalp N
    Acta Haematol; 2005; 113(2):109-12. PubMed ID: 15802889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia.
    Adly AA; Ragab IA; Ismail EA; Farahat MM
    Platelets; 2015; 26(7):645-50. PubMed ID: 25350586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
    Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
    Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Multiple myeloma developing in a patient with immune thrombocytopenia].
    Itoh T
    Rinsho Ketsueki; 2016 May; 57(5):630-3. PubMed ID: 27263790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The correlation of serum immunoglobulin free light chain levels and selected biological markers in multiple myeloma.
    Pika T; Minarik J; Schneiderka P; Budikova M; Langova K; Lochman P; Bacovsky J; Farbiakova V; Scudla V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):61-4. PubMed ID: 18795076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
    Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
    Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. N Latex FLC serum free light-chain assays in patients with renal impairment.
    Jacobs JF; Hoedemakers RM; Teunissen E; Te Velthuis H
    Clin Chem Lab Med; 2014 Jun; 52(6):853-9. PubMed ID: 24406282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tacrolimus has immunosuppressive effects on heavy/light chain pairs and free light chains in patients after heart transplantation: A relationship with infection.
    Lavríková P; Sečník P; Kubíček Z; Jabor A; Hošková L; Franeková J
    Transpl Immunol; 2018 Oct; 50():43-47. PubMed ID: 29913223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports.
    Gagliardi A; Carbone C; Russo A; Cuccurullo R; Lucania A; Cioppa PD; Misso G; Caraglia M; Tommasino C; Mastrullo L
    Oncol Lett; 2016 Oct; 12(4):2363-2370. PubMed ID: 27698801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma.
    Le Bricon T; Bengoufa D; Benlakehal M; Bousquet B; Erlich D
    Clin Biochem; 2002 Oct; 35(7):565-7. PubMed ID: 12493586
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients.
    Harutyunyan NM; Vardanyan S; Ghermezi M; Gottlieb J; Berenson A; Andreu-Vieyra C; Berenson JR
    Br J Haematol; 2016 Jul; 174(1):81-7. PubMed ID: 27017948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Within-subject biological variation of pairs of heavy/light immunoglobulin IgM chains (HLC IgM κ and λ) is low and requires monitoring: A comparison with HLC IgA, HLC IgG, and free light immunoglobulin chains (FLC) in healthy subjects.
    Jabor A; Kubíček Z; Komrsková J; Sečník P; Vacková T; Vymětalík J; Franeková J
    Clin Chim Acta; 2018 Nov; 486():311-312. PubMed ID: 30125534
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple Myeloma.
    Caillon H; Avet-Loiseau H; Attal M; Moreau P; Decaux O; Dejoie T
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e228-e237. PubMed ID: 30799237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study of the clonal characteristics of autoantibodies in chronic idiopathic thrombocytopenic purpura].
    Hou M; Shi Y; Peng J; Li W; Ma DX; Zhang MH
    Zhonghua Nei Ke Za Zhi; 2004 Feb; 43(2):87-9. PubMed ID: 15059401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical usefulness of serum free light chains measurement in patients with multiple myeloma: comparative analysis of two different tests.
    Kubicki T; Dytfeld D; Baszczuk A; Wysocka E; Komarnicki M; Lewandowski K
    Postepy Hig Med Dosw (Online); 2017 Jan; 71(0):40-46. PubMed ID: 28181910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
    Lutteri L; Aldenhoff MC; Cavalier E
    Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
    Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
    Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.